Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research.

There are 133 (licensed) beds in Roswell Park Cancer Institute; Grace Cancer Drug Center.

During the past decade, Roswell Park Cancer Institute; Grace Cancer Drug Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Roswell Park Cancer Institute; Grace Cancer Drug Center" are "Diffuse Large B-Cell Lymphoma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Roswell Park Cancer Institute; Grace Cancer Drug Center" in a lesser frequency.

Most popular intervention types in "Roswell Park Cancer Institute; Grace Cancer Drug Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Azacitidine" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "Polatuzumab Vedotin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Roswell Park Cancer Institute; Grace Cancer Drug Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Roswell Park Cancer Institute; Grace Cancer Drug Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Roswell Park Cancer Institute; Grace Cancer Drug Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Roswell Park Cancer Institute; Grace Cancer Drug Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".